B. Riley Issues Pessimistic Estimate for Celsius Earnings

Key Points

• B. Riley revised its earnings estimates for Celsius Holdings, projecting Q3 2025 earnings of $0.21 per share, slightly down from the previous forecast of $0.22.
• Despite the estimate downgrade, Celsius recently reported a Q2 earnings surprise, achieving $0.47 EPS, beating analysts' expectations of $0.23 by a significant margin.
• Several analysts have reiterated "buy" ratings for Celsius, increasing price targets, with an average target now at $51.72, indicating ongoing market confidence in the company's performance.

Celsius Holdings Inc. (NASDAQ:CELH - Free Report) - B. Riley decreased their Q3 2025 earnings estimates for shares of Celsius in a research report issued to clients and investors on Friday, August 8th. B. Riley analyst J. Van. Sinderen now expects that the company will earn $0.21 per share for the quarter, down from their prior forecast of $0.22. B. Riley has a "Buy" rating and a $56.00 price objective on the stock. The consensus estimate for Celsius' current full-year earnings is $0.89 per share. B. Riley also issued estimates for Celsius' FY2025 earnings at $0.83 EPS, FY2026 earnings at $1.28 EPS and FY2027 earnings at $1.77 EPS.

Celsius (NASDAQ:CELH - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.47 EPS for the quarter, beating analysts' consensus estimates of $0.23 by $0.24. Celsius had a net margin of 7.91% and a return on equity of 36.88%. The firm had revenue of $739.30 million for the quarter, compared to the consensus estimate of $632.13 million. During the same period in the prior year, the firm posted $0.28 EPS. The firm's revenue was up 83.9% compared to the same quarter last year.

Other analysts have also recently issued reports about the stock. Needham & Company LLC reissued a "buy" rating and set a $60.00 target price (up from $55.00) on shares of Celsius in a report on Thursday. Maxim Group increased their target price on shares of Celsius from $50.00 to $65.00 and gave the stock a "buy" rating in a report on Friday. JPMorgan Chase & Co. increased their target price on shares of Celsius from $44.00 to $54.00 and gave the stock an "overweight" rating in a report on Thursday, July 31st. Citigroup increased their target price on shares of Celsius from $55.00 to $60.00 and gave the stock a "buy" rating in a report on Friday. Finally, Wall Street Zen raised shares of Celsius from a "hold" rating to a "buy" rating in a report on Saturday. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $51.72.

Celsius Stock Up 3.7%

Shares of NASDAQ:CELH opened at $51.95 on Monday. The stock has a market capitalization of $13.39 billion, a price-to-earnings ratio of 140.41, a price-to-earnings-growth ratio of 1.80 and a beta of 1.40. Celsius has a 1-year low of $21.10 and a 1-year high of $53.85. The company's fifty day moving average is $44.51 and its two-hundred day moving average is $36.21. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 2.11.

Hedge Funds Weigh In On Celsius

Large investors have recently bought and sold shares of the stock. ProShare Advisors LLC boosted its position in shares of Celsius by 3.9% during the 2nd quarter. ProShare Advisors LLC now owns 6,970 shares of the company's stock valued at $323,000 after purchasing an additional 261 shares in the last quarter. Spire Wealth Management boosted its position in shares of Celsius by 12.0% during the 1st quarter. Spire Wealth Management now owns 2,677 shares of the company's stock valued at $95,000 after purchasing an additional 287 shares in the last quarter. Wealthcare Advisory Partners LLC boosted its position in shares of Celsius by 3.2% during the 1st quarter. Wealthcare Advisory Partners LLC now owns 9,718 shares of the company's stock valued at $346,000 after purchasing an additional 301 shares in the last quarter. TD Private Client Wealth LLC boosted its position in shares of Celsius by 8.8% during the 1st quarter. TD Private Client Wealth LLC now owns 4,071 shares of the company's stock valued at $145,000 after purchasing an additional 328 shares in the last quarter. Finally, GAMMA Investing LLC boosted its position in shares of Celsius by 19.7% during the 1st quarter. GAMMA Investing LLC now owns 2,052 shares of the company's stock valued at $73,000 after purchasing an additional 338 shares in the last quarter. Institutional investors and hedge funds own 60.95% of the company's stock.

Insider Buying and Selling at Celsius

In other Celsius news, CEO John Fieldly sold 143,167 shares of the firm's stock in a transaction dated Thursday, August 7th. The shares were sold at an average price of $51.18, for a total transaction of $7,327,287.06. Following the transaction, the chief executive officer owned 895,410 shares of the company's stock, valued at approximately $45,827,083.80. This trade represents a 13.78% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder Deborah Desantis sold 100,000 shares of the firm's stock in a transaction dated Thursday, July 31st. The shares were sold at an average price of $47.50, for a total transaction of $4,750,000.00. Following the transaction, the insider directly owned 17,717,770 shares in the company, valued at approximately $841,594,075. The trade was a 0.56% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 1,106,141 shares of company stock valued at $51,985,705. Company insiders own 2.20% of the company's stock.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.